BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Colorcon
Teva
Harvard Business School
Queensland Health
Healthtrust
AstraZeneca
UBS
Federal Trade Commission

Generated: January 20, 2018

DrugPatentWatch Database Preview

NIMODIPINE Drug Profile

« Back to Dashboard

Drug patent expirations by year for NIMODIPINE
Pharmacology for NIMODIPINE
Medical Subject Heading (MeSH) Categories for NIMODIPINE

US Patents and Regulatory Information for NIMODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc NIMODIPINE nimodipine CAPSULE;ORAL 076740-001 Jan 17, 2008 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc NIMODIPINE nimodipine CAPSULE;ORAL 077067-001 Apr 17, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Heritage Pharms Inc NIMODIPINE nimodipine CAPSULE;ORAL 077811-001 May 2, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sofgen Pharms NIMODIPINE nimodipine CAPSULE;ORAL 201832-001 Jul 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Thepharmanetwork Llc NIMODIPINE nimodipine CAPSULE;ORAL 090103-001 Apr 7, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Queensland Health
Daiichi Sankyo
Julphar
Chubb
Federal Trade Commission
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot